Mouse model of testosterone-induced muscle fiber hypertrophy: Involvement of p38 mitogen-activated protein kinase-mediated Notch signaling

Journal of Endocrinology

Volumn 201, Issue 1, 2009, Pages 129-139

  Brown, Danielle ^a   Sinha Hikim, Amiya P ^b   Kovacheva, Ekaterina L ^a   Sinha Hikim, Indrani ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLINE; GONADORELIN ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOGENIN; NOTCH RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TESTOSTERONE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; MYOG PROTEIN, MOUSE; PYRIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GASTROCNEMIUS MUSCLE; MALE; MOUSE; MUSCLE CELL; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHAM PROCEDURE; SIGNAL TRANSDUCTION; TESTOSTERONE BLOOD LEVEL; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; HYPERTROPHY; METABOLISM; MUSCLE DISEASE; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME INHIBITORS; HYPERTROPHY; IMIDAZOLES; MALE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCULAR DISEASES; MYOGENIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROLIFERATING CELL NUCLEAR ANTIGEN; PYRIDINES; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TESTOSTERONE;

EID: 67651022162     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0476     Document Type: Article

References (35)

1. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W & Dalton JT 2006 Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice. Endocrinology & Metabolism 2 146-159.
2. Braga M, Sinha Hikim AP, Datta S, Ferrini M, Brown D, Kovacheva EL, Gonzalez-Cadavid NF & Sinha-Hikim I 2008 Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis 13 822-832.
3. Caughlan A, Newhouse K, Namgung U & Xia Z 2004 Chlorpyrifos induces apoptosis in rat cortical neurons that is regulated by a balance between p38 and ERK/JNK MAP kinases. Toxicological Science 78 125-134.
4. Child ES & Mann DJ 2006 The intricacies of p21 phosphorylation: protein/ protein interactions, subcellular localization and stability. Cell Cycle 5 1313-1319.
5. Conboy IM & Rando TA 2002 The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Developmental Cell 3 397-409.
6. Conboy IM, Conboy MJ, Smythe GM & Rando TA 2003 Notch-mediated restoration of regenerative potential to aged muscle. Science 302 1575-1577.
7. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL & Rando TA 2005 Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 760-764.
8. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR & Lee JC 1995 SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Letters 364 229-233.
9. Huang Z, Chen D, Zhang K, Yu B, Chen X & Meng J 2007 Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cellular Signalling 19 2286-2295.
10. Hyatt J-PK, McCall GE, Kander EM, Zhong H, Roy RR & Huey KA 2008 Pax3/7 expression coincides with myoD during chronic skeletal muscle overload. Muscle & Nerve 38 861-866.
11. Johnson GL & Lapadat R 2002 Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 1911-1912.
12. Johnson C, Jia Y, Wang C, Lue Y, Swerdloff RS, Zhang X-S, Hu Z-Y, Li Y-C, Liu Y-X & Sinha Hikim AP 2008 Role of caspase 2 in apoptotic signaling of primate and murine germ cells. Biology of Reproduction 79 806-814.
13. Kawada S, Okuno M & Ishii N 2006 Testosterone causes decrease in the content of skeletal muscle myostatin. International Journal of Sport and Health Sciences 4 44-48.
14. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K,Wohlgemuth SE, Hofer T, Seo AY, Sulivan R, Jobling WA et al. 2005 Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309 481-484.
15. Lahti A, Kankaanranta H & Moilanen E 2002 p38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production. European Journal of Pharmacology 454 115-123.
16. Liang Q & Mollkentin JD 2003 Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. Journal of Molecular and Cellular Cardiology 35 1385-1394.
17. Lin A & Dibling B 2002 The true face of JNK activation in apoptosis. Aging Cell 1 112-116.
18. Lluis F, Perdiguero E, Nebreda AR & Munoz-Canoves P 2006 Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends in Cell Biology 16 36-44.
19. McPherron AC, Lawler AM & Lee SJ 1997 Regulation of skeletal muscle mass by a new TGF-beta superfamily member. Nature 387 83-90.
20. Mendler L, Baka Z, Kovacs-Simon A & Dux L 2007 Androgens negatively regulate myostatin expression in an androgen-dependent skeletal muscle. Biochemical and Biophysical Research Communications 361 237-242.
21. Morgan JE & Partridge TA 2003 Cells in focus: muscle satellite cells. International Journal of Biochemistry and Cell Biology 35 1151-1156.
22. Morissette MR, Cook SA, Foo SY, McKoy G, Ashida N, Novikov M, Scherrer-Crosbie M, Li L, Matsui T, Brooks G et al. 2006 Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circulation 99 15-24.
23. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ & Gonzalez-Cadavid NF 2003 Lower skeletal muscle mass in male transgenic mice with muscle specific overexpression of myostatin. American Journal of Physiology-Endocrinology and Metabolism 285 E876-E888.
24. Sciote JJ, Horton MJ, Zyman Y & Pascoe G 2001 Differential effects of diminished oestrogen and androgen levels on development of skeletal muscle fibers in hypogonadal mice. Acta Physiologica Scandinavica 172 179-187.
25. Sinha-Hikim I, Artaza J, Woodhouse L, Cadavid NG, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R & Bhasin S 2002 Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. American Journal of Physiology-Endocrinology and Metabolism 283 E154-E164.
26. Sinha-Hikim I, Roth SM, Lee MI & Bhasin S 2003 Testosterone induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. American Journal of Physiology-Endocrinology and Metabolism 285 E197-E205.
27. Sinha Hikim AP, Vera Y, Elhag RI, Lue Y, Cui Y-G, Pope V, Leung A, Atienza V, Wang C & Swerdloff RS 2005 Mouse model of male germ cell apoptosis in response to a lack of hormonal stimulation. Indian Journal of Experimental Biology 43 1048-1057.
28. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML & Bhasin S 2006 Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community dwelling, older men. Journal of Clinical Endocrinology and Metabolism 91 3024-3033.
29. 2-terminal kinase and nitric oxide-mediated mitochondria-dependent intrinsic pathway signaling in cardiotoxin-induced muscle cell death: role of testosterone. Apoptosis 12 1965-1978.
30. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J & Kambadur R 2000 Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. Journal of Biological Chemistry 275 40235-40243.
31. Venken K, Moverare-Skrtic S, Kopchick J, Coschigano KT, Ohlsson C, Boonen S, Bouillion R & Vanderschueren D 2007 Impact of androgens, growth hormone, and IGF-1 on bone and muscle in male mice during puberty. Journal of Bone and Mineral Research 22 72-82.
32. Vianzof M, Ayub-Guerrieri D, Onofre PCG, Martinus PCM, Lopes VF, Zilberztajn D, Maria LS, Sell K & Yamamoto LU 2008 Animal models for genetic neuromascular diseases. Journal of Molecular Neuroscience 34 241-248.
33. Wada T & Penninger JM 2004 Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 2838-2849.
34. Wagers A & Conboy IM 2005 Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122 659-667.
35. Weijzen S, Rizzo P, Braid M, Vishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC et al. 2002 Activation of Notch-1 signaling maintains neoplastic phenotype in human Ras-transformed cells. Nature Medicine 8 979-986.